Log in to your Inderes Free account to see all free content on this page.
Herantis Pharma
2.02 EUR
-2.88 %
4,550 following
Corporate customer
HRTIS
First North Finland
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
Valuation
Income statement
Quarterly estimates
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Herantis Pharma
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| growth-% | 150.0 % | ||||||||||
| EBITDA | -8.5 | -9.7 | -8.1 | 0.2 | -5.0 | -5.5 | -6.6 | -11.2 | -11.5 | ||
| EBIT (adj.) | -8.1 | -12.5 | -8.0 | 0.2 | -5.0 | -5.5 | -6.6 | -11.2 | -11.5 | ||
| EBIT | -8.1 | -12.5 | -8.0 | 0.2 | -5.0 | -5.5 | -6.6 | -11.2 | -11.5 | ||
| Profit before taxes | -8.6 | -12.8 | -9.3 | 0.3 | -5.0 | -6.0 | -6.6 | -11.2 | -11.5 | ||
| Net income | -8.6 | -12.8 | -9.3 | 0.3 | -5.0 | -6.0 | -6.6 | -11.2 | -11.5 | ||
| EPS (adj.) | -0.88 | -1.15 | -0.55 | 0.01 | -0.25 | -0.25 | -0.28 | -0.46 | -0.48 | ||
| growth-% | -1,895.3 % | ||||||||||
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA-% | -213,375.0 % | -243,525.0 % | -201,825.0 % | 3,850.0 % | -50,270.0 % | -55,119.0 % | -66,408.0 % | -111,995.0 % | -115,100.0 % | ||
| EBIT-% (adj.) | -201,775.0 % | -311,525.0 % | -199,825.0 % | 3,850.0 % | -50,270.0 % | -55,119.0 % | -66,408.0 % | -111,995.0 % | -115,100.0 % | ||
| EBIT-% | -201,775.0 % | -311,525.0 % | -199,825.0 % | 3,850.0 % | -50,270.0 % | -55,119.0 % | -66,408.0 % | -111,995.0 % | -115,100.0 % | ||
| ROE | -226.6 % | -396.1 % | 1,541.2 % | 12.0 % | -226.5 % | 752.5 % | 143.6 % | 82.7 % | 46.2 % | ||
| ROI | -109.1 % | -119.5 % | -151.8 % | 3.3 % | -222.0 % | -443.3 % | -442.7 % | -4,479.8 % | -4,604.0 % |
Login required
This content is only available for logged in users